Max Planck Institute for Molecular Biomedicine

Building of the institute at the Röntgenstrasse in Münster.

The Max Planck Institute for Molecular Biomedicine was founded on 1 April 2001 in Münster, North Rhine-Westphalia, Germany. It is part of the Max Planck Society. The managing director is Prof. Dr. Ralf H. Adams.

History

The Institute was founded on the 1st August 2001 in Münster, Germany. Founding director was Prof. Dr. Dietmar Vestweber. In 2004 another department was added (Prof. Dr. Hans Robert Schöler). In the same year, the institute got its current name: Max Planck Institute for Molecular Biomedicine. In 2006 the institute moved to a new and modern building offering more space and equipment. At the end of 2007 another department was added (Prof. Dr. Ralf H. Adams). This department moved from the Cancer Research UK London Research Institute to the MPI.

Departments

• Department 1 (Prof. Dr. Dietmar Vestweber): Vascular Cell Biology
• Department 2 (Prof. Dr. Hans Robert Schöler): Cell and Developmental Biology
• Department 3 (Prof. Dr. Ralf H. Adams): Tissue Morphogenesis

Research

Department 1

Department 1 (Vascular Cell Biology) is concentrating its research on leukocyte migration into inflammatory sites.

Department 2

Department 2 (Cell and Developmental Biology) works on germline development and pluripotency.

Department 3

Department 3 (Tissue Morphogenesis) works on how cells make tissue, in particular blood vessels.

Degree programme

• The MPI for Molecular Biomedicine offers a Master of Science and a PhD in Molecular Biomedicine together with the University of Münster. Both degree programmes are taught in English.

External links

• Official site
• International Max Planck Research School - Molecular Biomedicine (IMPRS-MBM)